[go: up one dir, main page]

PE20071323A1 - {6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL}-((R)-1-FENIL-ETIL)-AMINA EN EL TRATAMIENTO DE CANCER - Google Patents

{6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL}-((R)-1-FENIL-ETIL)-AMINA EN EL TRATAMIENTO DE CANCER

Info

Publication number
PE20071323A1
PE20071323A1 PE2007000072A PE2007000072A PE20071323A1 PE 20071323 A1 PE20071323 A1 PE 20071323A1 PE 2007000072 A PE2007000072 A PE 2007000072A PE 2007000072 A PE2007000072 A PE 2007000072A PE 20071323 A1 PE20071323 A1 PE 20071323A1
Authority
PE
Peru
Prior art keywords
phenyl
ethyl
ilmrtil
piperazin
amine
Prior art date
Application number
PE2007000072A
Other languages
English (en)
Inventor
Michael Mutz
Reto Fisher
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37946476&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20071323A1 publication Critical patent/PE20071323A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UNA FORMA CRISTALINA DE {6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDN-4-IL}-((R)-1-FENIL-ETIL)-AMINA, CARACTERIZADA POR UN PATRON DE DIFRACCION DE RAYOS X, EXPRESADO EN TERMINOS DE 2 THETA ANGULOS, QUE INCLUYE 5 O MAS PICOS SELECCIONADOS DE 4.4; 8.8; 9.1; 13.2; 14.2; 17.2; 18.2; 19.4+-0.2. Y UN ESPECTRO DE ABSORCION INFRARROJA CON BANDAS DE ABSORCION A APROXIMADAMENTE 695, 802, 836, 923, 1013, 1095, 1146, 1165, 1207, 1229, 1292, 1300, 1310, 1348, 1358, 1507, 1546, 1595, Y 3269 +-2 cm-1. REFERIDA TAMBIEN A UN PROCEDIMIENTO DE PREPARACION. DICHO COMPUESTO INHIBE A EFG Y VEGF UTILES EN EL CANCER DE MAMA, CANCER DE COLON, OVARIO, ENTRE OTROS
PE2007000072A 2006-01-23 2007-01-23 {6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL}-((R)-1-FENIL-ETIL)-AMINA EN EL TRATAMIENTO DE CANCER PE20071323A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76122406P 2006-01-23 2006-01-23

Publications (1)

Publication Number Publication Date
PE20071323A1 true PE20071323A1 (es) 2008-02-15

Family

ID=37946476

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000072A PE20071323A1 (es) 2006-01-23 2007-01-23 {6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL}-((R)-1-FENIL-ETIL)-AMINA EN EL TRATAMIENTO DE CANCER

Country Status (13)

Country Link
EP (1) EP1979357A1 (es)
JP (1) JP2009523768A (es)
KR (1) KR20080095859A (es)
CN (1) CN101370814A (es)
AR (1) AR059090A1 (es)
AU (1) AU2007206925A1 (es)
BR (1) BRPI0706729A2 (es)
CA (1) CA2636954A1 (es)
PE (1) PE20071323A1 (es)
RU (1) RU2008134314A (es)
TN (1) TNSN08312A1 (es)
TW (1) TW200738719A (es)
WO (1) WO2007082946A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
GB0119249D0 (en) * 2001-08-07 2001-10-03 Novartis Ag Organic compounds
JP2005507424A (ja) * 2001-10-29 2005-03-17 ノバルティス アクチエンゲゼルシャフト 固形腫瘍の処置における7H−ピロロ[2,3−d]ピリミジン誘導体の使用
US20080227980A1 (en) * 2005-08-05 2008-09-18 Novartis Ag Preparation of a 7H-Pyrrolo [2,3-D] Pyrimidine Derivative

Also Published As

Publication number Publication date
CN101370814A (zh) 2009-02-18
AU2007206925A1 (en) 2007-07-26
WO2007082946A1 (en) 2007-07-26
JP2009523768A (ja) 2009-06-25
TNSN08312A1 (en) 2009-12-29
CA2636954A1 (en) 2007-07-26
BRPI0706729A2 (pt) 2011-04-05
EP1979357A1 (en) 2008-10-15
KR20080095859A (ko) 2008-10-29
TW200738719A (en) 2007-10-16
AR059090A1 (es) 2008-03-12
RU2008134314A (ru) 2010-02-27

Similar Documents

Publication Publication Date Title
IL261964A (en) Transformed gasoline compounds
ES2488165T3 (es) Hidrocloruro de nalmefeno dihidrato
GB0801565D0 (en) Wavelength normalized depolarization ratio lidar
PE20080974A1 (es) Nuevas pirozolopirimidinas como inhibidores de quinasa dependientes de ciclina
TWI367221B (en) Hardmask composition having antireflective properties, process for forming patterned material layer by using the composition and semiconductor integrated circuit device produced using the process
EP1857520A4 (en) COMPOSITION FOR FORMING A HEAT-STORING OBJECT, HEAT-STORING OBJECT AND MANUFACTURING METHOD FOR A HEAT-STORING OBJECT
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
MX2019015200A (es) Compuestos de diarilhidantoina.
PT1859793E (pt) Uso combinado inovador de um composto de sulfonamida no tratamento oncológico
WO2013006864A3 (en) Treating cancer with hsp90 inhibitory compounds
IL183060A0 (en) Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents
DE502008000766D1 (de) Blasmaschine mit Garniturteilhalter, sowie Garniturteilhalter
JP2012036197A5 (es)
IL200764A (en) Preparations containing 3epha antibodies for use in the treatment of cancerous tumors
EP2048141A4 (en) OPTICALLY PURE DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF VIRUSES
DK1893210T3 (da) Selektiv apoptotisk induktion i cancerceller, herunder aktivering af procaspase-3
PE20071323A1 (es) {6-[4-(4-ETIL-PIPERAZIN-1-ILMRTIL)-FENIL]-7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL}-((R)-1-FENIL-ETIL)-AMINA EN EL TRATAMIENTO DE CANCER
IL180256A0 (en) Pyrido-pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer
DE502006009099D1 (de) Baumaschine, sowie schwenkeinrichtung
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
EP1886117A4 (en) REDUCTION OF THE THIN-FACE INTERFERENCE OF A SAMPLE OF REFLECTED ENERGY FLUCTUATIONS
EP2177495A4 (en) PROCESS FOR PRODUCING TRIPHENYLENE COMPOUND AND CRYSTALS OBTAINED THEREBY
WO2010149688A3 (en) Antitumoral compounds
EP1911812A4 (en) METHOD FOR PRODUCING MELANIN, MELLANIN PRODUCED BY THE METHOD, FUNCTIONAL FILM CONTAINING MELANIN, AND PROCESS FOR PRODUCING THE FILM

Legal Events

Date Code Title Description
FC Refusal